IL227658D0 - Pharmaceutical compositions comprising human antibodies to pcsk9

143 members in 41 offices

This recordMember, by publication datePriority claim31 more offices are in the list below

Priority claims33

Priority claims
Document	Office	Kind	Date
11305088	European Patent Office (EPO)	A	2011-01-28
11305089	European Patent Office (EPO)	A	2011-01-28
11305513	European Patent Office (EPO)	A	2011-04-29
11305514	European Patent Office (EPO)	A	2011-04-29
11306039	European Patent Office (EPO)	A	2011-08-12
11306040	European Patent Office (EPO)	A	2011-08-12
11306201	European Patent Office (EPO)	A	2011-09-22
11306202	European Patent Office (EPO)	A	2011-09-22
11306449	European Patent Office (EPO)	A	2011-11-08
11306450	European Patent Office (EPO)	A	2011-11-08
2012051321	European Patent Office (EPO)	W	2012-01-27
113050884	–	–	–
113050892	–	–	–
113055131	–	–	–
113055149	–	–	–
113060396	–	–	–
113060404	–	–	–
113062012	–	–	–
113062020	–	–	–
113064497	–	–	–
113064505	–	–	–
EP20110305088	–	–	–
EP20110305089	–	–	–
EP20110305513	–	–	–
EP20110305514	–	–	–
EP20110306039	–	–	–
EP20110306040	–	–	–
EP20110306201	–	–	–
EP20110306202	–	–	–
EP20110306449	–	–	–
EP20110306450	–	–	–
PCTEP2012051321	–	–	–
WO2012EP51321	–	–	–

Members143

Family members, oldest first
Document	Office	Kind
EP2481758A1	European Patent Office (EPO)	A1	2012-08-01
CA2825778A1	Canada	A1	2012-08-02
CA2825838A1	Canada	A1	2012-08-02
WO2012101251A1	World Intellectual Property Organization (WIPO)	A1	2012-08-02
WO2012101252A2	World Intellectual Property Organization (WIPO)	A2	2012-08-02
WO2012101253A1	World Intellectual Property Organization (WIPO)	A1	2012-08-02
TW201242613A	Taiwan Province of China	A	2012-11-01
TW201242614A	Taiwan Province of China	A	2012-11-01
TW201242615A	Taiwan Province of China	A	2012-11-01
WO2012146776A1	World Intellectual Property Organization (WIPO)	A1	2012-11-01
WO2012101252A3	World Intellectual Property Organization (WIPO)	A3	2012-11-15
AR084937A1	Argentina	A1	2013-07-10
AR084938A1	Argentina	A1	2013-07-10
AR084939A1	Argentina	A1	2013-07-10
AU2012210480A1	Australia	A1	2013-08-22
AU2012210481A1	Australia	A1	2013-08-22
SG192117A1	Singapore	A1	2013-08-30
CO6751276A2	Colombia	A2	2013-09-16
CO6751277A2	Colombia	A2	2013-09-16
ECSP13012792A	Ecuador	A	2013-09-30
IL227657A0	Israel	A0	2013-09-30
IL227657D0	Israel	D0	2013-09-30
IL227658A0	Israel	A0	2013-09-30
IL227658D0This record	Israel	D0	2013-09-30
SG192118A1	Singapore	A1	2013-09-30
MX2013008669A	Mexico	A	2013-10-01
MX2013008672A	Mexico	A	2013-10-01
CR20130406A	Costa Rica	A	2013-10-09
EP2650016A1	European Patent Office (EPO)	A1	2013-10-16
DOP2013000170A	Dominican Republic	A	2013-11-30
EP2668211A1	European Patent Office (EPO)	A1	2013-12-04
EP2668212A2	European Patent Office (EPO)	A2	2013-12-04
NI201300064A	Nicaragua	A	2013-12-17
CN103476796A	China	A	2013-12-25
CN103476797A	China	A	2013-12-25
KR20140006013A	Republic of Korea	A	2014-01-15
KR20140012075A	Republic of Korea	A	2014-01-29
MA34923B1	Morocco	B1	2014-02-01
CL2013002162A1	Chile	A1	2014-02-21
EP2702413A1	European Patent Office (EPO)	A1	2014-03-05
US2014065649A1	United States of America	A1	2014-03-06
PE20140372A1	Peru	A1	2014-03-24
ZA201305524B	South Africa	B	2014-03-26
CL2013002161A1	Chile	A1	2014-03-28
JP2014508142A	Japan	A	2014-04-03
GT201300186A	Guatemala	A	2014-04-29
JP2014511361A	Japan	A	2014-05-15
US2014154262A1	United States of America	A1	2014-06-05
US2014178402A1	United States of America	A1	2014-06-26
AR088782A1	Argentina	A1	2014-07-10
MA35800B1	Morocco	B1	2014-12-01
TN2013000322A1	Tunisia	A1	2015-01-20
RU2013139727A	Russian Federation	A	2015-03-10
RU2013139736A	Russian Federation	A	2015-03-10
NZ613867A	New Zealand	A	2015-09-25
NZ613870A	New Zealand	A	2015-12-24
ZA201305565B	South Africa	B	2016-01-27
BR112013018877A2	Brazil	A2	2016-10-04
RU2603481C2	Russian Federation	C2	2016-11-27
RU2604139C2	Russian Federation	C2	2016-12-10
US9561155B2	United States of America	B2	2017-02-07
UA113728C2	Ukraine	C2	2017-03-10
TW201711698A	Taiwan Province of China	A	2017-04-01
MX347602B	Mexico	B	2017-05-03
AU2012210480B2	Australia	B2	2017-05-18
AU2012210481B2	Australia	B2	2017-05-18
JP2017095490A	Japan	A	2017-06-01
JP2017095491A	Japan	A	2017-06-01
US9682013B2	United States of America	B2	2017-06-20
AU2017216546A1	Australia	A1	2017-09-07
AU2017216547A1	Australia	A1	2017-09-07
US2017266079A1	United States of America	A1	2017-09-21
US2017340515A1	United States of America	A1	2017-11-30
MY165159A	Malaysia	A	2018-02-28
EP2668212B1	European Patent Office (EPO)	B1	2018-03-21
CN107899010A	China	A	2018-04-13
EP3326648A1	European Patent Office (EPO)	A1	2018-05-30
TWI625127B	Taiwan Province of China	B	2018-06-01
PT2668212T	Portugal	T	2018-06-28
DK2668212T3	Denmark	T3	2018-07-02
ES2674600T3	Spain	T3	2018-07-02
PE20181052A1	Peru	A1	2018-07-03
LT2668212T	Lithuania	T	2018-07-10
HRP20180959T1	Croatia	T1	2018-07-27
JP6375113B2	Japan	B2	2018-08-15
PL2668212T3	Poland	T3	2018-08-31
RS57339B1	Serbia	B1	2018-08-31
SI2668212T1	Slovenia	T1	2018-08-31
TWI635870B	Taiwan Province of China	B	2018-09-21
EP3395836A1	European Patent Office (EPO)	A1	2018-10-31
RU2016142277A	Russian Federation	A	2018-12-17
RU2016142273A	Russian Federation	A	2018-12-18
JP2018203772A	Japan	A	2018-12-27
HUE039258T2	Hungary	T2	2018-12-28
BR112013018740A2	Brazil	A2	2019-01-08
IL227657A	Israel	A	2019-05-30
IL227657B	Israel	B	2019-05-30
IL265707A	Israel	A	2019-05-30
IL265707D0	Israel	D0	2019-05-30
KR20190062612A	Republic of Korea	A	2019-06-05

Showing 100 of 143

2 legal events, as the office reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code
2019-09-26	Patent renewedKB	KB
2019-08-29	Patent grantedGrantedFF	FF

Numbers

Publication, DOCDB: 227658
Publication, EPODOC: IL227658D
Application: 227658
Application, DOCDB: 22765813
Application, EPODOC: IL20130227658

Titles2

English: Pharmaceutical compositions comprising human antibodies to pcsk9
Hebrew: תכשירים רוקחיים המכילים נוגדנים הומניים ל–9pcsk

Classification

CPC, 26: A61J1/05
C07K16/40
A61K31/215
A61K39/3955
A61K39/00
G01N33/92
A61K31/366
C07K2317/76
A61K31/404
C07K2317/21
A61K31/435
G01N2800/044
A61K31/47
A61K2039/505
A61K31/505
A61K39/395
A61K45/06
C07K14/4703
A61P3/00
A61P3/06
A61P43/00
A61P5/00
A61P7/00
A61P9/00
A61P9/10
A61K2039/545
Filled: the office’s first classification
IPC, 1: C07K

Pharmaceutical compositions comprising human antibodies to pcsk9

Abstract

Term